Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.




This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Physicians who Treat Malignant Melanoma (US)(?)

Council Members in this Study Group: 156

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

What is a GLG Leader?
Taral Patel, MD, Oncologist, Mid Ohio Oncology Hematology Inc.Taral Patel, MD
Oncologist
Mid Ohio Oncology Hematology Inc.

Taral Patel, MD, is an Oncologist in private practice with Mid Ohio Oncology-Hematology, Inc. He treats patients with both cancer and blood disorders. Dr. Patel has been a principal investigator for multiple clinical trials in colon cancer, lung cancer, lymphoma, and growth factor. He has been on the...

Brian Lester, MD
Dermatologist
Brian W Lester, MD

Brian Lester, MD, is a Dermatologist in private practice in Massachusetts. His interests include clinical dermatology, cosmetic dermatology, dermatopathology, and dermatologic pharmaceuticals. He has experience with clinical trials involving a variety of agents used in psoriasis (e.g. retinoids and...

Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology, Stanford UniversitySunil Dhawan, MD
Clinical Assistant Professor of Dermatology
Stanford University

Sunil Dhawan, MD, is a Clinical Assistant Professor of Dermatology at Stanford University. He has expertise in clinical dermatology including acne, rosacea, psoriasis, eczema, skin cancer, actinic keratosis, lasers and cosmetic dermatology, and managed care. Dr. Dhawan also runs the clinical trial division...

Lawrence Tena, MD
Radiation Oncologist
St. Vincent's Comprehensive Cancer Center

Lawrence Tena, MD, is an Attending Physician in the Department of Radiation Oncology at St. Vincent's Comprehensive Cancer Center in New York. He is also an Assistant Professor of Radiation Oncology at the New York Medical College and an Associate Adjunct at the New York Eye and Ear Infirmary. Dr. Tena...

Eric Whitman, MD, Medical Director, Office of Grants and Research, Atlantic Health System IncEric Whitman, MD
Medical Director, Office of Grants and Research
Atlantic Health System Inc

Eric Whitman, MD, is a Medical Director of the Office of Grants and Research for Atlantic Health System in Morristown, New Jersey. He is a board certified General Surgeon with fellowship training in surgical oncology. He specializes in melanoma care, endocrine and oncologic surgery. Dr. Whitman is also...

GLG NewsSMAnalyses by this Study Group's Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Evolence Approval- what effect will it have on the filler market | 07-02-2008
Author: Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology, Stanford University

This article is important because it outlines the rationale and benefits of the new collagen based filler from Ortho-Neutrogena/ Johnson and Johnson. This filler appears to last at least 6 months, and does not require pre testing as other collagen based fillers have needed in the past. The fact that...

Adolesecnt acne treatable | 06-27-2008
Author: Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology, Stanford University

This article is important in that, for the most part , it describes a basic therapeutic regimen for adolescent acne patients. The only error is describing the inflamed lesions as "infections." Acne is predominantly an inflammatory condition, not an infectious one, though a bacteria is involved...

Allergan's acquisition of Aczone- is this significant? | 06-25-2008
Analysis of: Allergan Aquisition of Aczone | agn360.client.shareholder.com
Author: Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology, Stanford University

This article is important in that this acquisition is the first new product for Allergan's dermatology division in several years. This is also the first novel molecule in 5-7 years that has been released. The issues of having to get blood tests with this topical agent have been solved. The obvious paring...

You get what you pay for | 05-27-2008
Author: GLG Expert Contributor

A single payer, national system does work, but may not necessarily be in the best interest of all parties.   Yes this type of system is 'free' to the users, but is funded through higher taxes than paid in the US.

This article may change atopic dermatitis treatment by pediatricians | 05-19-2008
Author: Sunil Dhawan, MD, Clinical Assistant Professor of Dermatology, Stanford University

This article is important in that it is a good summary of the current knowledge and treatment methods for atopic dermatitis for pediatricians. It is needed in that this condition is inadequately treated, and a periodic refresher is needed for all physicians. Both pharmacologic and non pharmacologic...

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Non-Academic Community Hospital or Clinic

Most Common Job Types:

  • Physician - Attending Physician
  • Physician - Director
  • Owner
  • Director
  • Physician - Division Head
  • President
  • Physician - Department Chair

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics